-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Dhjs9hDMrTLY690+aQ5c3iv7MzlldkxR/T7vJFP6ucrFArQm0uXvmmxLu3Sgujpb
 W9QWYMtfWKUhhOE0BhxvoA==

<SEC-DOCUMENT>0000906344-06-000493.txt : 20061220
<SEC-HEADER>0000906344-06-000493.hdr.sgml : 20061220
<ACCEPTANCE-DATETIME>20061220202401
ACCESSION NUMBER:		0000906344-06-000493
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20061204
FILED AS OF DATE:		20061220
DATE AS OF CHANGE:		20061220

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FAMILYMEDS GROUP, INC.
		CENTRAL INDEX KEY:			0000921878
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				341755390
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		312 FARMINGTON AVENUE
		CITY:			FARMINGTON
		STATE:			CT
		ZIP:			06032-1968
		BUSINESS PHONE:		8606761222

	MAIL ADDRESS:	
		STREET 1:		312 FARMINGTON AVENUE
		CITY:			FARMINGTON
		STATE:			CT
		ZIP:			06032-1968

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DRUGMAX INC
		DATE OF NAME CHANGE:	20011128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DRUGMAX COM INC
		DATE OF NAME CHANGE:	20000208

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUTRICEUTICALS COM CORP
		DATE OF NAME CHANGE:	19990629

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			MEDCAP PARTNERS LP
		CENTRAL INDEX KEY:			0001176482

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15445
		FILM NUMBER:		061291243

	BUSINESS ADDRESS:	
		STREET 1:		500 THIRD STREET
		STREET 2:		SUITE 535
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94107
		BUSINESS PHONE:		415-495-1010

	MAIL ADDRESS:	
		STREET 1:		500 THIRD STREET
		STREET 2:		SUITE 535
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94107
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2006-12-04</periodOfReport>

    <issuer>
        <issuerCik>0000921878</issuerCik>
        <issuerName>FAMILYMEDS GROUP, INC.</issuerName>
        <issuerTradingSymbol>FMRX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001176482</rptOwnerCik>
            <rptOwnerName>MEDCAP PARTNERS LP</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>500 THIRD STREET #535</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>SAN FRANCISCO</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94107</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Warrants to Purchase Common Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>10.90</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2006-12-04</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>J</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
                <footnoteId id="F1"/>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>9084</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2010-10-02</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>9084</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>381371</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value></value>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">On September 30, 2006, the reporting person's general partner segregated a portion of the issuer's securities held by the reporting person into a separate account for the benefit of some of the reporting person's former limited partners. The dispositions of the issuer's securities reported on this Form 4 were made by the reporting person as in-kind distributions from the separate account to some of those former limited partners.</footnote>
        <footnote id="F2">The warrants became formally exercisable on April 3, 2006, but they are subject to restrictions that prohibit their exercise to the extent that the number of shares of the issuer's common stock beneficially owned by the reporting person, an affiliated offshore investment limited partnership, their respective affiliates and other persons whose beneficial ownership is aggregated with them would exceed 9.999% of the total number of issued and outstanding shares of the issuer's common stock (including for such purposes the shares of common stock issuable upon such exercise).</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>MedCap Partners L.P.; By: MedCap Management &amp; Research, LLC, its General Partner; By: C. Fred Toney, its Managing Member; /s/ C. Fred Toney</signatureName>
        <signatureDate>2006-12-20</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----